📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
JNK India Appoints Anand Agarwal as Interim CFO and Key Managerial Personnel
JNK India Limited has appointed Mr. Anand Agarwal as its Interim Chief Financial Officer and Key Managerial Personnel, effective March 12, 2026. Mr. Agarwal is a Chartered Accountant with 20 years of experience in finance leadership across the EPC, infrastructure, and oil & gas sectors. He will hold the position until a permanent CFO is appointed by the Board. This move ensures continuity in the company's financial governance and regulatory compliance following the board meeting held on March 12, 2026.
Key Highlights
Mr. Anand Agarwal appointed as Interim CFO and KMP effective March 12, 2026.
Brings 20 years of experience from senior roles at companies like Kalpataru Projects International Limited.
Expertise includes project finance, treasury, debt structuring, and ERP transformation.
Authorized by the Board to determine materiality of events for SEBI disclosures.
The appointment follows a Board Meeting concluded within 26 minutes on March 12, 2026.
💼 Action for Investors
Investors should view this as a routine management transition and monitor for the announcement of a permanent CFO appointment. The interim choice appears well-qualified with significant industry experience, suggesting minimal disruption to financial operations.
Fitch Upgrades Bank of India's Viability Rating to 'bb'; Affirms IDR at 'BBB-'
Fitch Ratings has upgraded Bank of India's (BOI) Viability Rating (VR) to 'bb' from 'bb-', signaling a stronger intrinsic financial profile. The bank's Long-Term Issuer Default Rating (IDR) remains affirmed at 'BBB-' with a Stable Outlook, reflecting high expectations of government support. Key financial metrics have shown marked improvement, with the impaired-loan ratio dropping to 2.3% in 9MFY26 and credit costs reducing to 0.4%. The bank maintains a healthy capital cushion with a CET1 ratio of 15.3%, well above regulatory requirements.
Key Highlights
Viability Rating (VR) upgraded to 'bb' from 'bb-' reflecting improved risk profile and asset quality.
Impaired-loan ratio improved significantly to 2.3% in 9MFY26 from 3.3% in the previous year.
Common Equity Tier 1 (CET1) ratio strengthened to 15.3%, providing a 400bp cushion over the rating threshold.
Credit costs declined to 0.4% of loans in 9MFY26, down from 1.0% in FY25.
Fitch affirmed the Long-Term Issuer Default Rating at 'BBB-' with a Stable Outlook.
💼 Action for Investors
The upgrade in the Viability Rating confirms the bank's improving fundamental health and better risk management. Investors should monitor if the bank can sustain these asset quality improvements while managing loan growth in a competitive environment.
Bank of India to Exercise Call Option on 9.30% AT1 Bonds Series VII
Bank of India has announced its decision to exercise the call option for its 9.30% Additional Tier I (AT1) Bonds Series VII. The bank has fixed March 13, 2026, as the record date to identify bondholders eligible for the redemption. The total payment, comprising the principal amount and interest for the broken period, will be disbursed on March 30, 2026. This move is a standard capital management procedure for bonds issued in March 2021 and indicates the bank's stable liquidity position.
Key Highlights
Exercise of call option for 9.30% Additional Tier I Bonds Series VII (ISIN: INE084A08144)
Record date for determining eligible bondholders is March 13, 2026
Full redemption of principal and interest scheduled for March 30, 2026
Bonds were originally issued on March 30, 2021, with a 5-year call option clause
💼 Action for Investors
Bondholders should ensure their bank and demat details are updated by March 13, 2026, to receive the redemption proceeds. Equity investors can view this as a routine capital management activity reflecting healthy liquidity.
JNK India Q3 FY26 PAT Surges 534% YoY to ₹180.2 Mn; Revenue Doubles to ₹2,062 Mn
JNK India reported a stellar Q3 FY26 with revenue growing 112.8% YoY to ₹2,062.3 million and PAT jumping 534.1% to ₹180.2 million. The company maintains a robust order book of approximately ₹1,700 crores, supported by domestic projects like BPCL Bina and international prospects like the Dangote refinery expansion. The newly formed JV with Chemdist contributed ₹23 crores in revenue this quarter, signaling progress in green hydrogen and sustainable fuels. Management highlighted a shift in accounting policy to the input method, which is expected to normalize margins moving forward.
Key Highlights
Revenue grew 112.8% YoY to ₹2,062.3 million with an operating profit margin of 27.2%
Net profit (PAT) witnessed a massive 534.1% YoY increase to ₹180.2 million
Order book remains strong at approximately ₹1,700 crores as of January 1, 2026
Subsidiary business (Chemdist JV) contributed ₹23 crores to revenue with a ₹100 crore order book
Management identified significant future opportunities in Nigeria (Dangote refinery) and the Middle East
💼 Action for Investors
Investors should view the strong revenue growth and healthy order pipeline as a positive sign of execution capability. Monitor the conversion of the Dangote refinery and Middle East bids as these are key catalysts for future growth.
JNK India Shareholders Approve Material Related Party Transactions; 36% Institutions Dissent
JNK India Limited has received shareholder approval for two material related party transactions (RPT) involving its subsidiary, JNK Chemdist Technologies. The resolutions passed with a 67.6% majority among voting public shareholders, as the promoter group abstained from voting due to being interested parties. While the resolutions were successful, a notable 36.4% of institutional votes were cast against the proposals. These transactions facilitate operational dealings between the parent, its subsidiary, and Chemdist Process Solutions.
Key Highlights
Both resolutions for material related party transactions passed with a 67.62% majority.
Public institutional participation was very high at 99.91%, though 36.40% of their votes were cast against the resolutions.
Promoters and the promoter group, holding 37.9 million shares, did not participate in the voting as interested parties.
The transactions involve JNK Chemdist Technologies Private Limited and Chemdist Process Solutions Private Limited.
A total of 9.91 million votes were polled out of the eligible public shareholding base.
💼 Action for Investors
Monitor future financial statements for the actual value and impact of these related party transactions on margins. The significant institutional dissent suggests investors should stay alert to corporate governance and arm's length pricing.
JNK India Q3 FY26 PAT Surges 534% YoY to ₹180.2 Mn; Order Book at ₹17,611 Mn
JNK India delivered a stellar performance in Q3 FY26, with revenue doubling to ₹2,062.3 Mn and PAT growing over six-fold to ₹180.2 Mn. The company's 9M FY26 revenue rose 67.2% YoY to ₹4,934.1 Mn, supported by a robust order book of ₹17,611 Mn which provides strong future visibility. EBITDA margins for the quarter improved significantly to 14.3% from 10.1% in the year-ago period. The company is successfully diversifying its portfolio with the commencement of operations at JNK Chemdist, focusing on sustainable fuels and chemicals.
Key Highlights
Q3 FY26 Revenue grew 112.8% YoY to ₹2,062.3 Mn compared to ₹969.2 Mn in Q3 FY25.
Q3 FY26 PAT skyrocketed 534.3% YoY to ₹180.2 Mn with PAT margins expanding to 8.7%.
Total order book stands at ₹17,611 Mn as of December 31, 2025, with a 9M inflow of ₹11,372 Mn.
Heating solutions remain the core segment, contributing 89.6% of the total order book.
9M FY26 ROCE and ROE reported at 13.6% and 8.3% respectively.
💼 Action for Investors
Investors should take note of the massive order book which is nearly 3.5x the 9M revenue, indicating strong growth potential. The significant margin expansion and successful entry into green energy segments through joint ventures make it a compelling growth story in the industrial equipment space.
JNK India Q3 FY26 PAT Jumps 534% YoY to ₹180.3 Mn; Order Book Hits ₹17,611 Mn
JNK India delivered exceptional Q3 FY26 results, with revenue growing 112.8% YoY to ₹2,062.3 million and PAT surging 534.3% to ₹180.3 million. The company's order book remains strong at ₹17,611 million, backed by ₹11,372 million in new inflows during the first nine months of the fiscal year. Profitability showed marked improvement, with EBITDA margins expanding to 14.3% in Q3 from 10.1% in the previous year. The strategic expansion into green hydrogen through the JNK Chemdist joint venture adds a high-growth vertical to its core heating equipment business.
Key Highlights
Q3 FY26 Revenue surged 112.8% YoY to ₹2,062.3 million, while 9M FY26 Revenue rose 67.2% to ₹4,934.1 million.
Net Profit (PAT) for Q3 FY26 skyrocketed by 534.3% YoY to ₹180.3 million.
Total Order Book reached ₹17,611 million as of December 31, 2025, with 89.6% coming from heating solutions.
EBITDA for Q3 FY26 increased by 202.8% YoY to ₹295.1 million, with margins expanding to 14.3%.
Petrochemicals sector accounts for 85.97% of the total order book, indicating high sector concentration.
💼 Action for Investors
Investors should view the massive earnings growth and robust order book as strong indicators of future performance, though sector concentration in petrochemicals remains a key monitorable. The successful integration and scaling of the JNK Chemdist venture into green hydrogen could provide a significant long-term valuation re-rating.
JNK India Q3 FY26 Net Profit Surges to ₹184.6M; Revenue Up 92% YoY
JNK India reported a stellar performance for the quarter ended December 31, 2025, with standalone revenue from operations growing 91.7% YoY to ₹1,789.45 million. Net profit witnessed a massive jump to ₹184.58 million compared to just ₹29.10 million in the same quarter last year. For the nine-month period, the company's profit nearly doubled to ₹332.07 million from ₹168.78 million. The company also announced the operationalization of its new subsidiary, JNK Chemdist Technologies, marking an expansion into the process equipment segment.
Key Highlights
Standalone Revenue from Operations grew 91.7% YoY to ₹1,789.45 million in Q3 FY26.
Net Profit for the quarter skyrocketed to ₹184.58 million from ₹29.10 million in Q3 FY25.
Basic EPS increased significantly to ₹3.30 in Q3 FY26 compared to ₹0.53 in the previous year's quarter.
Nine-month revenue reached ₹4,560.83 million, a 60.6% increase over the ₹2,839.11 million recorded in 9M FY25.
The company has successfully utilized ₹2,796.64 million of its IPO proceeds, primarily for working capital requirements.
💼 Action for Investors
The company demonstrates robust growth in both top-line and bottom-line, reflecting strong execution in its core fired heaters business. Investors should monitor the scaling of the newly operationalized 'Process Equipment' segment as a potential future growth driver.
JNK India Q3 FY26 Standalone PAT Surges 534% YoY to ₹184.6 Million; Revenue up 92%
JNK India reported a stellar performance for Q3 FY26, with standalone revenue from operations jumping 91.7% YoY to ₹1,789.45 million. The standalone net profit witnessed a massive growth of 534% YoY, reaching ₹184.58 million compared to ₹29.10 million in the corresponding quarter of the previous year. For the nine-month period ended December 2025, the company has already surpassed its full-year FY25 profit, recording a PAT of ₹332.07 million. Additionally, the company operationalized its new subsidiary, JNK Chemdist Technologies, marking its expansion into the process equipment segment.
Key Highlights
Standalone Revenue from Operations grew 91.7% YoY to ₹1,789.45 million in Q3 FY26.
Standalone Profit After Tax (PAT) skyrocketed 534% YoY to ₹184.58 million from ₹29.10 million.
9M FY26 Standalone PAT of ₹332.07 million has already exceeded the full-year FY25 PAT of ₹301.41 million.
Basic EPS for the quarter rose significantly to ₹3.30 from ₹0.53 in the year-ago period.
Utilized ₹2,796.64 million of IPO proceeds as of December 31, 2025, mainly for working capital requirements.
💼 Action for Investors
The company demonstrates strong execution capabilities and robust margin expansion, making it a positive outlook for growth-oriented investors. Monitor the performance of the newly operationalized 'Process Equipment' segment for further diversification benefits.
NK Industries Reports Q3 Net Loss of ₹69.55 Lakhs Amid Ongoing ₹937 Crore Legal Claims
NK Industries reported a net loss of ₹69.55 lakhs for the quarter ended December 31, 2025, compared to a loss of ₹14.56 lakhs in the same period last year. Total income remained stagnant at ₹73.38 lakhs, while the company continues to struggle with a severely eroded net worth and accumulated losses of ₹51,103.89 lakhs. The company remains embroiled in significant legal battles, including a ₹937 crore claim related to the NSEL scam and asset attachments under the MPID and PMLA acts. Auditors have issued a qualified opinion, stating they cannot quantify the final financial impact of these sub-judice matters.
Key Highlights
Net Loss widened to ₹69.55 lakhs in Q3 FY26 from ₹14.56 lakhs in Q3 FY25.
Total Income for the quarter was nearly flat at ₹73.38 lakhs compared to ₹71.17 lakhs YoY.
Company faces a massive legal claim of approximately ₹937 crores plus interest related to NSEL recovery proceedings.
Accumulated reserves stand at a deeply negative ₹51,103.89 lakhs, indicating severe financial distress.
Key operational assets including land and machinery remain attached by the ED and Maharashtra Government under PMLA and MPID acts.
💼 Action for Investors
Investors should avoid this stock due to its negative net worth, stagnant operations, and massive unresolved legal liabilities that threaten the company's existence. The audit qualifications regarding the inability to quantify potential losses add significant risk.
Mankind Pharma Subsidiary BSV Subjected to 6-Day GST Search and Inspection
The GST Department, Mumbai, conducted a search and inspection operation at Bharat Serums and Vaccines Limited (BSV), a wholly owned subsidiary of Mankind Pharma. The operation took place over six days, from February 3 to February 8, 2026, under Section 67 of the Maharashtra GST Act. The inspection focused on tax payments, input tax credit claims, reconciliation, and refunds. Mankind Pharma has officially stated that the search has resulted in no material impact on the subsidiary's financials or operations.
Key Highlights
Search conducted by Assistant Commissioner of State Tax (Investigation – B), Mumbai
Operation lasted 6 days from February 3 to February 8, 2026
Focus areas included GST tax payments, input tax credit (ITC) reconciliation, and refunds
Management confirms no material impact on BSV's financial or operational activities
BSV is a wholly owned unlisted subsidiary of Mankind Pharma Limited
💼 Action for Investors
Investors should monitor for any subsequent tax demand notices or penalties that may arise from this inspection. While the company claims no material impact, any future liability could affect the subsidiary's valuation.
Mankind Pharma Q3 FY26 Revenue Up 11.5% to ₹3,567 Cr; Adjusted EBITDA Margin at 25.9%
Mankind Pharma reported a steady Q3 FY26 with revenue growing 11.5% YoY to INR 3,567 crores, driven by an 11.1% increase in domestic sales and 14% growth in exports. The company's adjusted EBITDA margin stood at 25.9%, while the chronic segment's contribution rose to 36.7% of total sales. Integration of the BSV acquisition showed positive results with double-digit growth, and the company successfully reduced its net debt to INR 4,294 crores. Management highlighted a recovery in volume growth and significant outperformance in cardio and anti-diabetic therapies compared to the market.
Key Highlights
Q3 FY26 revenue increased 11.5% YoY to ₹3,567 crores with an adjusted EBITDA margin of 25.9%.
Chronic therapy contribution rose to 36.7%, with cardio and anti-diabetes growing at 16.7% and 14.4% respectively.
Export revenue for 9M FY26 surged 51% YoY to ₹1,503 crores, supported by EU GMP certification for the Udaipur facility.
Net debt reduced to ₹4,294 crores, bringing the net debt to adjusted EBITDA ratio down to 1.3x.
Domestic PCPM improved to ₹7.2 lakhs from ₹6.5 lakhs on a trailing 12-month basis.
💼 Action for Investors
Investors should monitor the continued integration of BSV and the recovery in the acute segment. The stock remains a strong play on the domestic chronic market and expanding export capabilities.
D-Link India Q3 PAT Rises to ₹9.73 Cr; Faces ₹6.11 Cr Customs Demand & Director Resignation
D-Link (India) reported a steady performance for Q3 FY26, with standalone revenue growing 12.7% year-on-year to ₹375.15 crore. Net profit for the quarter saw a marginal increase to ₹9.73 crore, up from ₹9.44 crore in the previous year's corresponding quarter. The company's bottom line was impacted by a one-time provision of ₹1.92 crore related to the implementation of New Labour Codes. Furthermore, the company is contesting a ₹6.11 crore customs demand regarding royalty payments, while Independent Director Ching Chun Yang has resigned effective February 5, 2026.
Key Highlights
Standalone Revenue from operations grew 12.7% YoY to ₹375.15 crore in Q3 FY26.
Net Profit (PAT) for the quarter stood at ₹9.73 crore compared to ₹9.44 crore in Q3 FY25.
Recognized ₹1.92 crore in incremental employee benefit obligations due to the New Labour Codes effective Nov 2025.
Received a customs demand order of ₹6.11 crore (including penalties) related to royalty payments on third-party imports.
Independent Director Ms. Ching Chun Yang resigned from the Board and all committees effective February 5, 2026.
💼 Action for Investors
Investors should monitor the legal proceedings regarding the ₹6.11 crore customs demand and the potential impact of higher employee costs under the New Labour Codes. While revenue growth is stable, the marginal profit growth suggests pressure on margins that warrants a cautious outlook.
D-Link India Q3 Revenue Rises 12.7% to ₹375 Cr; Independent Director Resigns
D-Link (India) Limited reported a steady Q3 FY26 with revenue from operations growing to ₹375.15 crore from ₹332.85 crore YoY. The company's Profit Before Tax remained stable at ₹12.99 crore despite a one-time charge of ₹1.92 crore related to the implementation of New Labour Codes. A significant regulatory update involves a customs demand of ₹6.11 crore regarding royalty payments, which the company is currently evaluating for appeal. Additionally, Independent Director Ms. Ching Chun Yang resigned from the board effective February 5, 2026.
Key Highlights
Revenue from operations increased 12.7% YoY to ₹375.15 crore for the quarter ended December 31, 2025.
Profit Before Tax stood at ₹12.99 crore, showing marginal growth over the ₹12.68 crore reported in Q3 FY25.
Recognized incremental employee benefit obligations of ₹1.92 crore due to the New Labour Codes effective November 2025.
Received a customs demand order of ₹6.11 crore (including penalties) related to royalty payments to the parent company.
Independent Director Ms. Ching Chun Yang resigned from the board and all committees effective February 5, 2026.
💼 Action for Investors
Investors should monitor the impact of the customs demand appeal and the company's ability to protect margins against rising regulatory and labor costs. The steady revenue growth suggests resilience in the networking products segment.
India Ratings Reaffirms Bank of India’s Infra and Tier 2 Bonds at ‘IND AA+/Stable’
India Ratings has reaffirmed the 'IND AA+/Stable' rating for Bank of India's Infrastructure bonds (₹150 billion) and Tier 2 bonds (₹25 billion). The bank's asset quality has shown significant improvement, with Gross NPA dropping to 2.26% and Net NPA to 0.6% as of 3QFY26. While capital adequacy remains strong at 17.09%, the bank faces pressure on its deposit profile, with the CASA ratio declining to 32.6%. The rating reflects the bank's systemic importance and the high probability of government support given the 73.38% state ownership.
Key Highlights
Reaffirmed 'IND AA+/Stable' rating for ₹150 billion Infrastructure and ₹25 billion Tier 2 bonds
Gross NPA improved to 2.26% in 3QFY26 from 3.27% in FY25; Net NPA stands at a low 0.6%
Capital Adequacy Ratio (CAR) remains healthy at 17.09% with a CET-1 ratio of 13.76%
Return on Assets (RoA) improved to 0.96% in 3QFY26, up from 0.70% in FY24
CASA ratio declined to 32.6%, highlighting ongoing challenges in low-cost deposit mobilization
💼 Action for Investors
Investors should take confidence in the improving asset quality and stable credit rating which supports the bank's growth outlook. Monitor the bank's deposit growth and CASA ratio as they remain key areas of competitive pressure.
D-Link India Q3 FY26 Revenue at ₹375.15 Cr; PBT Grows 33.5% YoY to ₹13 Cr
D-Link (India) Limited reported a steady year-on-year performance for the quarter ended December 31, 2025, with revenue from operations growing 12.7% to ₹375.15 crore. Profit Before Tax (PBT) saw a robust increase of 33.5% YoY, reaching ₹13 crore, although revenue dipped slightly on a sequential basis. The company is currently managing a regulatory challenge following a ₹6.11 crore customs demand related to royalty payments. Additionally, the firm has accounted for a ₹1.92 crore provision due to the implementation of New Labour Codes effective November 2025.
Key Highlights
Revenue from operations increased to ₹375.15 crore in Q3 FY26 from ₹332.85 crore in Q3 FY25.
Profit Before Tax (PBT) rose to ₹13.00 crore compared to ₹9.73 crore in the same quarter last year.
Received a customs demand order of ₹611.49 lakhs regarding royalty payments, which the company is evaluating for appeal.
Recognized incremental employee benefit obligations of ₹192.41 lakhs due to the implementation of New Labour Codes.
Independent Director Ms. Ching Chun Yang resigned from the Board and its committees effective February 5, 2026.
💼 Action for Investors
Investors should monitor the outcome of the customs demand appeal as it represents a potential liability. While YoY profit growth is strong, the sequential stagnation in revenue suggests a need to watch for signs of slowing demand in the networking products segment.
D-Link India Q3 FY26 Revenue Up 12.3% YoY to ₹375 Cr, Net Profit Drops 23% to ₹9.7 Cr
D-Link (India) reported a 12.3% YoY increase in revenue to ₹375.15 crore for the quarter ended December 31, 2025. However, net profit declined by 23.2% YoY to ₹9.73 crore, impacted by a one-time provision of ₹1.92 crore for New Labour Codes and higher operating expenses. The company is also contesting a customs demand of ₹6.11 crore related to royalty payments. Additionally, Independent Director Ms. Ching Chun Yang resigned from the board effective February 5, 2026.
Key Highlights
Revenue from operations grew 12.3% YoY to ₹375.15 crore compared to ₹333.99 crore in Q3 FY25.
Net profit for the quarter fell 23.2% YoY to ₹9.73 crore from ₹12.68 crore.
Recognized a one-time employee benefit obligation of ₹1.92 crore due to the implementation of New Labour Codes.
Received a customs demand order of ₹6.11 crore regarding royalty payments on imported goods.
Resignation of Independent Director Ms. Ching Chun Yang effective February 5, 2026.
💼 Action for Investors
Investors should be cautious as profit margins have contracted despite revenue growth, and the company faces legal hurdles regarding customs duties. Monitor the impact of the New Labour Codes on future operating margins.
NK Industries Approves Q3 FY26 Standalone and Consolidated Financial Results
NK Industries Limited has approved its unaudited standalone and consolidated financial results for the quarter and nine-month period ended December 31, 2025. The board meeting, held on February 4, 2026, also reviewed and accepted the Limited Review Report provided by the auditors. This announcement is a standard regulatory requirement under SEBI (LODR) Regulations. Investors should now examine the specific financial tables to assess the company's revenue and profit performance for the quarter.
Key Highlights
Board approved unaudited standalone and consolidated financial results for the quarter ended December 31, 2025.
The Limited Review Report for the nine-month period was formally taken on record.
The board meeting commenced at 3:30 P.M. and concluded at 5:00 P.M. on February 4, 2026.
Compliance maintained with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
💼 Action for Investors
Investors should review the detailed profit and loss statements and balance sheet figures once the full report is available to evaluate the company's growth trajectory. Compare these results with previous quarters to identify any significant changes in operational margins.
NK Industries Approves Q3 FY26 Unaudited Standalone and Consolidated Financial Results
NK Industries Limited has officially approved its unaudited financial results for the quarter and nine months ended December 31, 2025. The Board of Directors met on February 4, 2026, to review both standalone and consolidated performance. While the specific financial figures were not detailed in this outcome summary, the approval includes the mandatory Limited Review Report. This meeting ensures compliance with SEBI Listing Obligations and Disclosure Requirements.
Key Highlights
Approval of Unaudited Standalone Financial Results for the quarter ended December 31, 2025
Approval of Unaudited Consolidated Financial Results for the 9-month period of FY26
Limited Review Reports for both standalone and consolidated results were formally accepted
The board meeting was conducted between 3:30 P.M. and 5:00 P.M. on February 4, 2026
Compliance maintained under Regulation 30 of SEBI (LODR) Regulations, 2015
💼 Action for Investors
Investors should review the detailed financial tables once published to assess the company's revenue growth and margin stability. Compare the Q3 results against the previous year's corresponding quarter to identify long-term performance trends.
Mankind Pharma Q3 FY26 Standalone PAT at ₹449.47 Cr; Revenue at ₹2,632.68 Cr
Mankind Pharma reported a steady performance for Q3 FY26 with standalone revenue from operations at ₹2,632.68 crore, showing a marginal sequential dip from ₹2,636.95 crore in Q2. Standalone Profit After Tax (PAT) stood at ₹449.47 crore, slightly lower than the ₹462.27 crore reported in the previous quarter, partly due to an exceptional item of ₹83.42 crore. The financial results have been restated to account for the acquisition of Bharat Serums and Vaccines Limited (BSV) and other business combinations. Overall, the company maintains a strong balance sheet with a total comprehensive income of ₹452.53 crore for the quarter.
Key Highlights
Standalone Revenue from operations stood at ₹2,632.68 crore for the quarter ended December 31, 2025.
Standalone Profit After Tax (PAT) reached ₹449.47 crore, impacted by an exceptional charge of ₹83.42 crore.
Basic Earnings Per Share (EPS) for the quarter was reported at ₹10.89.
Financials were restated to reflect the impact of the Bharat Serums and Vaccines Limited (BSV) acquisition.
Total expenses for the quarter were managed at ₹2,100.49 crore compared to ₹2,189.09 crore in the preceding quarter.
💼 Action for Investors
Investors should monitor the integration progress of the BSV acquisition and the reasons behind the exceptional item. While sequential growth was flat, the company's domestic market leadership remains a key long-term positive.